Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00331175 | Safety, Toleration and Pharmacokinetics of Single Intravenous Doses of Peptide YY in Overweight Adults | PHASE1 | COMPLETED | 31 | — | — | Jul 1, 2006 | Dec 1, 2006 | Dec 15, 2006 | 1 | United States |
| Name | Type | Description |
|---|---|---|
| Peptide YY3-36 | DRUG | - |
Inclusion Criteria: * BMI 27-35 kg/m2 Exclusion Criteria: * Women of childbearing potential